Safety and efficacy of N-acetylcysteine (NAC) as an adjunct to standard treatment in patients with acute ischemic stroke: a randomized controlled pilot trial (NACTLYS).

Sci Rep · 2024 · PMC10784280 · PMID 38212360

Europe PMC DOI

hedged sentence

0.7700

closest p · 15.4× alpha

0.7700

boldest claim

The sentences

did not reach statistical significancep = 0.77not close (p > 0.1)

The disparity in the median onset to door time between the two groups did not reach statistical significance ( p = 0.77) (Fig.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.